Skip to content

N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide

C20H19FN4O5 — CID 68703562

Data last refreshed: (MolForge compound catalog, from PubChem)

IUPACN-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide
SMILESCOc1ccccc1Cn1c(=O)c(OC)nn(-c2ccc(F)c(NC(C)=O)c2)c1=O
InChIInChI=1S/C20H19FN4O5/c1-12(26)22-16-10-14(8-9-15(16)21)25-20(28)24(19(27)18(23-25)30-3)11-13-6-4-5-7-17(13)29-2/h4-10H,11H2,1-3H3,(H,22,26)
InChIKeyLYJFXBYWEQHQEM-UHFFFAOYSA-N
MW414.39 g/mol
LogP1.56
Rot. Bonds6

About N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide

N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide (PubChem CID 68703562) has the molecular formula C20H19FN4O5 and a molecular weight of 414.39 g/mol. Its IUPAC name is N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide.

Molecular Properties

Compound NameN-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide
PubChem CID68703562
Molecular FormulaC20H19FN4O5
Molecular Weight414.39 g/mol
Exact Mass414.13
IUPAC NameN-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide
SMILESCOc1ccccc1Cn1c(=O)c(OC)nn(-c2ccc(F)c(NC(C)=O)c2)c1=O
InChIInChI=1S/C20H19FN4O5/c1-12(26)22-16-10-14(8-9-15(16)21)25-20(28)24(19(27)18(23-25)30-3)11-13-6-4-5-7-17(13)29-2/h4-10H,11H2,1-3H3,(H,22,26)
InChIKeyLYJFXBYWEQHQEM-UHFFFAOYSA-N
XLogP1.56
TPSA104.45 Ų
H-Bond Donors1
H-Bond Acceptors8
Rotatable Bonds6
Heavy Atoms30
Complexity—

Lipinski Rule of Five

Passes Rule of Five

RuleValue
MW ≤ 500414.39
LogP ≤ 51.56
H-Bond Donors ≤ 51
H-Bond Acceptors ≤ 108

Analyze N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide?
The IUPAC name of N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide (CID 68703562) is N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide.
What is the SMILES notation for N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide?
The canonical SMILES for N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide is COc1ccccc1Cn1c(=O)c(OC)nn(-c2ccc(F)c(NC(C)=O)c2)c1=O.
What is the InChIKey of N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide?
The InChIKey is LYJFXBYWEQHQEM-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H19FN4O5/c1-12(26)22-16-10-14(8-9-15(16)21)25-20(28)24(19(27)18(23-25)30-3)11-13-6-4-5-7-17(13)29-2/h4-10H,11H2,1-3H3,(H,22,26).
What are the key properties of N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide?
N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide has a molecular weight of 414.39 g/mol, XLogP of 1.56, 6 rotatable bonds, 1 hydrogen bond donors, and 8 hydrogen bond acceptors.
Where does this data come from?
All data for N-[2-fluoro-5-[6-methoxy-4-[(2-methoxyphenyl)methyl]-3,5-dioxo-1,2,4-triazin-2-yl]phenyl]acetamide is sourced from PubChem (CID 68703562), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).

Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.